|
Re: Another possibility?
|
2
|
Zenith Epigenetics
|
Dec 10, 2015 10:20AM
|
|
Re: Recent ESC 2017 meeting and Steve Nissans comments
|
2
|
Resverlogix Corp.
|
Sep 11, 2017 02:31PM
|
|
Re: ALNY/BTI
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 21, 2017 10:16AM
|
|
Re: TEN BUSINESS DAYS GOING FORWARD!
|
2
|
Resverlogix Corp.
|
Sep 21, 2015 11:08AM
|
|
Re: Flu vs. Covid19
|
2
|
Resverlogix Corp.
|
Apr 02, 2020 07:16AM
|
|
Re: NR on phase 1 Kidney Trial
|
2
|
Resverlogix Corp.
|
Jan 23, 2017 11:45AM
|
|
Re: Double Halts? Double the Fun? Double Trouble?
|
2
|
Resverlogix Corp.
|
Jul 07, 2015 12:30PM
|
|
Re: Article in Nature - An epigenetics gold rush: new controls for gene expression
|
2
|
Resverlogix Corp.
|
Feb 23, 2017 10:04AM
|
|
Re: Technical Difficulties
|
2
|
Resverlogix Corp.
|
Oct 11, 2017 01:12PM
|
|
Re: Zenith AGM Corporation Update Slides and Webcast
|
2
|
Zenith Epigenetics
|
Nov 20, 2019 11:02AM
|
|
Re: plenty of scenarios being put out there...
|
2
|
Zenith Epigenetics
|
Dec 11, 2015 12:01PM
|
|
Re: The Feb 26th DSMB PR.....re-examined.
|
2
|
Resverlogix Corp.
|
May 14, 2018 07:10AM
|
|
Re: BIO Investor Forum
|
2
|
Resverlogix Corp.
|
Oct 01, 2017 01:53PM
|
|
Re: Sarah's response...
|
2
|
Resverlogix Corp.
|
Apr 25, 2017 08:15PM
|
|
Re: Tailwinds Research biOasis video
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 09, 2017 10:48AM
|
|
Resverlogix's Manuscript on RVX-208 Accepted into the Atherosclerosis Journal
|
2
|
Resverlogix Corp.
|
Jan 25, 2016 01:51PM
|
|
Re: AGM
|
2
|
Resverlogix Corp.
|
Dec 17, 2020 11:22AM
|
|
96 hours
|
2
|
Resverlogix Corp.
|
Aug 22, 2017 11:02AM
|
|
Re: Bear....
|
2
|
Resverlogix Corp.
|
Jun 09, 2019 10:21PM
|
|
Re: Looking over Amarin does lead to one obvious conclusion...
|
2
|
Resverlogix Corp.
|
Feb 14, 2019 12:09PM
|
